Lilly’s Experimental Shot Cuts Body Weight by 23% in Study
A next-generation obesity shot from Eli Lilly & Co. helped patients lose almost a quarter of their body weight, potentially making the…
Tag: Lillys
Eli Lilly’s newest weight-loss drug relieved pain in patients with knee osteoarthritis
Eli Lilly’s “triple g” drug helped patients lose about 28.7% of their body weight while also reducing pain associated with…
The market likes what it heard from the Fed — plus, Lilly’s new $6B manufacturing investment
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time…
Novo Undercuts Lilly’s Obesity Drug Price for Cash-Pay Patients
Novo Nordisk A/S is undercutting arch-rival Eli Lilly & Co. on obesity drugs for cash-pay patients, showing its willingness to…
Why cutting drug prices is pushing Eli Lilly’s stock toward an all-time high
Even by dramatically lowering the prices of some of its medications, the drug giant is still outpacing its rivals and…
Eli Lilly’s amylin obesity drug shows up to 20% weight loss in study
Eli Lilly Biotechnology Center is shown in San Diego, California, March 1, 2023. Mike Blake | Reuters Eli Lilly on…
Tech rules Monday’s stock market — plus, Eli Lilly’s big comeback
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time…
Eli Lilly’s (LLY) Focus on Innovation and Financial Strength Makes it a Long-Term Winner
Eli Lilly and Company (NYSE:LLY) is included among the 10 Best Rising Dividend Stocks to Buy Now. Eli Lilly’s (LLY)…
Jim Cramer Highlights Eli Lilly’s Drug Potential Beyond Diabetes and Obesity
Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer put under the microscope. Cramer highlighted the importance…
4 reasons to like Wells, Lilly’s latest launch, Boeing ramps production
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time…